367 related articles for article (PubMed ID: 20105592)
21. Pediatric ovarian tumors--dilemmas in diagnosis and management.
Ruttenstock EM; Saxena AK; Schwinger W; Sorantin E; Hoellwarth ME
Eur J Pediatr Surg; 2010 Mar; 20(2):116-20. PubMed ID: 20112185
[TBL] [Abstract][Full Text] [Related]
22. Management and outcomes of ovarian masses in children and adolescents.
Islam S; Yamout SZ; Gosche JR
Am Surg; 2008 Nov; 74(11):1062-5. PubMed ID: 19062661
[TBL] [Abstract][Full Text] [Related]
23. Urgency of evaluation and outcome of acute ovarian torsion in pediatric patients.
Anders JF; Powell EC
Arch Pediatr Adolesc Med; 2005 Jun; 159(6):532-5. PubMed ID: 15939851
[TBL] [Abstract][Full Text] [Related]
24. Comparison of underlying lesions in pediatric and adult ovarian torsion.
Aktas S; Yigit S; Diniz G; Pehlivan FS; Ortac R
Saudi Med J; 2006 Aug; 27(8):1183-6. PubMed ID: 16883449
[TBL] [Abstract][Full Text] [Related]
25. Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study.
Burger RA; Darcy KM; DiSaia PJ; Monk BJ; Grosen EA; Gatanaga T; Granger GA; Wang J; Tian C; Hanjani P; Cohn DE
Cancer; 2004 Jul; 101(1):106-15. PubMed ID: 15221995
[TBL] [Abstract][Full Text] [Related]
26. Current management of malignant germ cell tumor of the ovary.
Aziz MF
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
[TBL] [Abstract][Full Text] [Related]
27. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
28. Validation of referral guidelines for women with pelvic masses.
Im SS; Gordon AN; Buttin BM; Leath CA; Gostout BS; Shah C; Hatch KD; Wang J; Berman ML
Obstet Gynecol; 2005 Jan; 105(1):35-41. PubMed ID: 15625139
[TBL] [Abstract][Full Text] [Related]
29. Cannot exclude torsion--a 15-year review.
Oltmann SC; Fischer A; Barber R; Huang R; Hicks B; Garcia N
J Pediatr Surg; 2009 Jun; 44(6):1212-6; discussion 1217. PubMed ID: 19524743
[TBL] [Abstract][Full Text] [Related]
30. Managing ovarian masses during pregnancy.
Leiserowitz GS
Obstet Gynecol Surv; 2006 Jul; 61(7):463-70. PubMed ID: 16787549
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy.
Padungsutt P; Thirapagawong C; Senapad S; Suphanit I
Anticancer Res; 2000; 20(2B):1291-5. PubMed ID: 10810437
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
33. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
34. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
35. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
36. [Adnexal masses management: a prospective multicentric observational study].
Huchon C; Bats AS; Bensaïd C; Junger M; Nos C; Chatellier G; Lécuru F
Gynecol Obstet Fertil; 2008 Nov; 36(11):1084-90. PubMed ID: 18964176
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2006 Sep; 102(3):542-5. PubMed ID: 16510173
[TBL] [Abstract][Full Text] [Related]
38. [Preoperative diagnosis of malignancy of ovarian space-occupying lesions with special reference to new, laparoscopic surgical techniques].
Roch G
Wien Klin Wochenschr; 1995; 107(17):529-31. PubMed ID: 7483637
[No Abstract] [Full Text] [Related]
39. Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis.
Sørensen SS; Mosgaard BJ
Dan Med Bull; 2011 Nov; 58(11):A4331. PubMed ID: 22047929
[TBL] [Abstract][Full Text] [Related]
40. Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma.
Geisler JP; Miller GA; Lee TH; Harwood RM; Wiemann MC; Geisler HE
J Reprod Med; 1996 Mar; 41(3):140-2. PubMed ID: 8778409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
